RxDoctor Payments DataLook up a doctor →

Julie Pilitsis, MD

Neurological Surgery · Tucson, AZNPI 1861559163

Payments from drug & device makers

$762,129in general payments, 2019–2025

Across 453 payments — averaging $1682.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$312K
  • Nevro Corp.$177K
  • Medtronic$97K
  • Boston Scientific$69K
  • Surgical Information Sciences, Inc.$37K
  • Saluda Medical Americas, Inc.$33K
  • plus $38K from 10 others
$44,879in research payments, 2019–2025

Across 16 payments — averaging $2804.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Nevro Corp.$36K
  • Medtronic$7K
  • Saluda Medical Americas, Inc.$2K

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$762,129 in reported general payments places this provider in the 90th percentile of 173 neurological surgery providers in Arizona.

See all neurological surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$52,159
Medicare patients
62
Services billed
127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →